Medical robotics, healthcare technology, and innovation by Stereotaxis
Stereotaxis, Inc. cites 500 peer-reviewed publications on robotic electrophysiology safety and efficacy
Stereotaxis, Inc. announced that over 500 peer-reviewed publications have validated the safety, efficacy, and efficiency of its robotic electrophysiology solutions. The company encouraged ...
Stereotaxis, Inc. unveils remote access technology in cardiology test drive event
Stereotaxis, Inc. is set to conduct a live remote test drive showcasing its latest cardiology innovations between France and the U.S. The demonstration will take place during the Journées de ...
Stereotaxis, Inc. advances robotic precision to transform patient care
Stereotaxis, Inc. is accelerating the adoption of robotic technology aimed at delivering unprecedented precision in patient care. The company is spotlighting its RoboticEP system, designed to ...
Stereotaxis opens recruitment for impact-driven candidates
Stereotaxis, Inc. has initiated a hiring campaign aimed at attracting professionals passionate about healthcare and innovation. The company is inviting applicants to explore a range of open ...
Stereotaxis, Inc. touts robotic technology to address physician burnout and improve patient care
Stereotaxis, Inc. draws attention to the growing issue of physician burnout while promoting RoboticEP as a solution to support medical professionals. The company claims that its robotic ...
Stereotaxis, Inc. spotlights RoboticEP system during interactive sessions at HRS2026
Stereotaxis, Inc. participated in the first day of HRS2026, holding engaging discussions with leading electrophysiologists and offering hands-on experiences with its GenesisX and RoboticEP ...
Stereotaxis, Inc. enables first U.S. robotic arm procedures for complex CHD cases
Stereotaxis, Inc. has enabled the first robotic arm procedures in the U.S. for complex congenital heart disease (CHD) patients, using its MAGiC system. The initial case involved a patient with ...
Stereotaxis, Inc. sets sights on HRS2026 with live robotics demonstration
Stereotaxis, Inc. is preparing for its next appearance at HRS2026 following participation at EHRA2026. The company will feature a live demonstration of its GenesisX system and provide ...
Stereotaxis, Inc. urges final day visits at EHRA2026 for hands on robotic EP demonstrations
Stereotaxis, Inc. is calling for attendees to visit its booth on the last day of the EHRA2026 event to experience its latest electrophysiology technology in action. The company is offering ...
Stereotaxis, Inc. promotes GenesisX at EHRA2026 kickoff in Paris
Stereotaxis, Inc. initiated its participation at EHRA2026 in Paris with a dynamic start, inviting attendees to visit its booth for an introduction to the GenesisX platform. The company coupled ...
Stereotaxis, Inc. gains FDA clearance for Synchrony robotics system
Stereotaxis, Inc. has received clearance from the U.S. Food and Drug Administration for its Synchrony robotic system. This regulatory milestone supports the company’s efforts to advance ...
Live-in-the-Box robotic session to feature Sabine Ernst at EHRA2026, Stereotaxis, Inc. unveils
Stereotaxis, Inc. announced the upcoming launch of its Live-in-the-Box session at EHRA2026, taking place in 10 days. The session will spotlight Prof. Sabine Ernst as she demonstrates the power ...
Stereotaxis, Inc. expands remote robotic testing with TeleRobotic Test Drive launch
Stereotaxis, Inc. has unveiled its remote TeleRobotic Test Drive, allowing users to experience its RoboticEP technology without the need to travel. The company is encouraging prospective clients ...
Stereotaxis, Inc. to unveil new robotic EP solutions at EHRA2026 in Paris
Stereotaxis, Inc. is set to present its newest advancements in robotic electrophysiology at the upcoming EHRA2026 conference in Paris. The company aims to demonstrate cutting-edge technologies ...
Stereotaxis, Inc. gears up for EHRA2026 with robotic EP technology preview
Stereotaxis, Inc. is preparing to attend the upcoming EHRA2026, inviting industry professionals to schedule meetings with its team. The company plans to present the latest advances in robotic ...
32.4 million revenue surges over 20 percent with regulatory wins, Stereotaxis asserts
Stereotaxis reported revenue of 32.4 million, marking growth exceeding 20 percent compared to the previous year. The company announced regulatory approvals for its GenesisX, MAGiC, and MAGiC ...
Stereotaxis, Inc. schedules Q4 and full year 2025 earnings call for 4:30 PM ET
Stereotaxis, Inc. has scheduled its Q4 and full year 2025 earnings call for today at 4:30 PM ET. Investors can access the webcast through the company’s website using the provided event link. ...
Robotic technology shields patients and doctors from radiation, Stereotaxis asserts
Stereotaxis, Inc. advocates for its robotic electrophysiology system as a solution to reducing radiation exposure during medical procedures. The company claims its RoboticEP technology offers ...
Stereotaxis, Inc. promotes direct experience of RoboticEP benefits through interactive demonstration
Stereotaxis, Inc. urges users to witness the tangible benefits of its RoboticEP technology through an online demonstration. The company highlights that the advantages of robotic ...
